- Trials with a EudraCT protocol (2,999)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (31)
2,999 result(s) found for: C value.
Displaying page 1 of 150.
EudraCT Number: 2014-005179-10 | Sponsor Protocol Number: ISS16694 | Start Date*: 2015-07-27 |
Sponsor Name:Charalampos Vlachopoulos | ||
Full Title: Effect of long-term testosterone replacement therapy on arterial stiffness and endothelial function in male patients with hypogonadism | ||
Medical condition: Male patients with hypogonadism | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: GR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003522-83 | Sponsor Protocol Number: SM1-PJ-13 | Start Date*: 2013-10-04 | |||||||||||
Sponsor Name:Professor Jørgen B. Dahl | |||||||||||||
Full Title: Adductor canal block and effect of 10 versus 30 ml ropivacaine on muscle strength: a randomized study in helathy volunteers | |||||||||||||
Medical condition: healthy volunteers (treatment intended for postoperative pain treatment in patients after knee surgery) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000755-40 | Sponsor Protocol Number: ATB200-03 | Start Date*: 2019-04-08 | |||||||||||
Sponsor Name:Amicus Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 3 Double-blind Randomized Study to Assess the Efficacy and Safety of Intravenous ATB200 Co-administered With Oral AT2221 in Adult Subjects With Late Onset Pompe Disease Compared With Algluc... | |||||||||||||
Medical condition: Adult Subjects With Late Onset Pompe Disease (LOPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) DK (Completed) GB (GB - no longer in EU/EEA) SE (Completed) HU (Completed) BE (Completed) SK (Completed) ES (Completed) NL (Completed) BG (Prematurely Ended) SI (Completed) GR (Completed) AT (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002429-12 | Sponsor Protocol Number: UC_0160/1613 | Start Date*: 2018-01-31 |
Sponsor Name:UNICANCER | ||
Full Title: PERSONALIZED TREATMENT OF METASTATIC CASTRATE-RESISTANT PROSTATE CANCER PATIENTS ACCORDING TO CIRCULATING TUMOR CELLS KINETIC DURING CHEMOTHERAPY | ||
Medical condition: Metastatic castrate-resistant prostate cancer requiring initiation of chemotherapy | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004103-12 | Sponsor Protocol Number: ISOTOVE | Start Date*: Information not available in EudraCT |
Sponsor Name:Centre Jean Perrin | ||
Full Title: ISOTOVE study Isotopic study of the intraperitoneal distribution of locoregional post surgery chemotherapy for peritoneal carcinomatosis of ovarian origin | ||
Medical condition: peritoneal carcinomatosis of ovarian origin | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001885-14 | Sponsor Protocol Number: LOWBACK-SE | Start Date*: 2019-08-06 |
Sponsor Name:National Research, Development and Innovation Office | ||
Full Title: The prognostic value of Biomarkers and the Effect of Tolperisone in Acute low back pain and sciatic pain – BETA A Phase 3 investigator initiated study | ||
Medical condition: Acute low back pain with or withour radicular signs | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004671-12 | Sponsor Protocol Number: s55892 | Start Date*: 2014-06-20 |
Sponsor Name:University of Leuven | ||
Full Title: Predictive value of biomarkers in patients with amnestic mild cognitive impairment | ||
Medical condition: Mild cognitive impairment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-013763-19 | Sponsor Protocol Number: CQAB149BIT01 | Start Date*: 2009-09-24 | |||||||||||
Sponsor Name:NOVARTIS FARMA | |||||||||||||
Full Title: Multicenter, randomized, blinded, placebo controlled, cross over, single dose study to assess the effect of indacaterol (150 �g) versus tiotropium (18 �g) on Inspiratory Capacity in moderate COPD p... | |||||||||||||
Medical condition: moderate COPD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011445-13 | Sponsor Protocol Number: IJB-BGDO-2009-001 | Start Date*: 2009-11-26 |
Sponsor Name:Institut Jules Bordet-Université Libre de Bruxelles | ||
Full Title: Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer | ||
Medical condition: Stage III colon adenocarcinoma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000351-95 | Sponsor Protocol Number: R727-CL-1628 | Start Date*: 2017-07-18 | |||||||||||
Sponsor Name:Regeneron Pharmaceuticals, Inc. | |||||||||||||
Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALIROCUMAB IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | |||||||||||||
Medical condition: HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) AT (Completed) GR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001011-21 | Sponsor Protocol Number: LITA-001 | Start Date*: 2016-06-01 |
Sponsor Name:Litaphar S.L. | ||
Full Title: A prospesctive, open-label 12-weeks treatment study to determine the effect of tadalafil 5 mg on clitoral blood flow in menopausal and hipertensive women with sexual interest and arousal disorder | ||
Medical condition: Sexual interest and arousal disorder in menopausal and hierpertensive women | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-004601-32 | Sponsor Protocol Number: SM4-UG-14 | Start Date*: 2015-01-07 | |||||||||||
Sponsor Name:Gentofte Hospital | |||||||||||||
Full Title: The Effect of Local Anesthetic Volume within the Adductor Canal on Quadriceps Function Evaluated by Electromyography: A Randomized, Observer-Masked, Placebo-Controlled Study in Volunteers. | |||||||||||||
Medical condition: Healthy volunteers. Results will be used for optimizing the treatment of post-operative pain after total knee arthroplasty | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002303-18 | Sponsor Protocol Number: ISS112 | Start Date*: 2012-11-02 |
Sponsor Name:VU University Medical Center (VUmc) | ||
Full Title: The Dutch Flutemetamol in Young Dementia Study | ||
Medical condition: Young (age of diagnosis ≤ 70 years) patients with (suspicion of) dementia with at least some doubt about etiological diagnosis. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003228-20 | Sponsor Protocol Number: 155-CL-007 | Start Date*: 2006-01-12 | |||||||||||
Sponsor Name:Yamanouchi Europe B.V. (to be renamed Astellas Pharma Europe B.V by August 2005) | |||||||||||||
Full Title: A PHASE II, MULTI-CENTER, OPEN-LABEL STUDY OF YM155 IN SUBJECTS WITH HORMONE REFRACTORY PROSTATE CANCER (HRPC) PREVIOUSLY TREATED WITH AT LEAST ONE PRIOR CHEMOTHERAPY REGIMEN | |||||||||||||
Medical condition: Male adults with Hormone Refractory Prostate Cancer who have progressed, as evidenced by PSA progression or progression of measurable disease, after at least 1 prior chemotherapy regimen. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000299-15 | Sponsor Protocol Number: BC1-03 | Start Date*: 2004-11-03 |
Sponsor Name:Algeta AS | ||
Full Title: A double-blind, dose-response, phase II, multicentre study of radium-223 (Alpharadin TM ) for the palliation of painful bone metastases in hormone refractory prostate cancer patients | ||
Medical condition: The target population is patients suffering from bone pain due to skeletal metastasis secondary to prostate cancer. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: SE (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-002316-24 | Sponsor Protocol Number: TAK-475/EC304 | Start Date*: 2005-09-27 | |||||||||||
Sponsor Name:Takeda Europe R &D Centre Ltd | |||||||||||||
Full Title: A placebo-controlled, double-blind, randomised study to evaluate the efficacy and safety of TAK-475 100mg in subjects with type 2 diabetes currently treated with lipid-lowering therapy. | |||||||||||||
Medical condition: treatment of patients with primary dyslipidaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) FI (Completed) EE (Completed) SK (Completed) CZ (Completed) DE (Completed) DK (Completed) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002154-36 | Sponsor Protocol Number: CIGE025F1301 | Start Date*: 2019-02-13 | ||||||||||||||||
Sponsor Name:Novartis Pharma KK | ||||||||||||||||||
Full Title: A 12 Week, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Omalizumab in Adult and Adolescent Patients With Inadequately Controlled... | ||||||||||||||||||
Medical condition: Severe Japanese cedar pollinosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2023-000382-14 | Sponsor Protocol Number: mRNA-1273-P203 | Start Date*: 2023-12-29 |
Sponsor Name:ModernaTX, Inc. | ||
Full Title: A Phase 2/3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adolescents 12 to <18 Years of... | ||
Medical condition: Coronavirus Disease 2019 | ||
Disease: | ||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2021-001059-15 | Sponsor Protocol Number: 2021-PSMA-CZT | Start Date*: 2022-04-05 |
Sponsor Name:Fysiologiska Kliniken, Linköping US | ||
Full Title: The value of 99mTc-MIP-1404 SPECT/CT Veriton CZT for staging of prostate cancer and before primary therapy and in biochemical recurrence after radical prostatectomy. Fase II study. | ||
Medical condition: Prostate cancer. Please see the study protocol. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002547-29 | Sponsor Protocol Number: ATB-203 | Start Date*: 2019-11-21 | ||||||||||||||||||||||||||
Sponsor Name:Atox Bio | ||||||||||||||||||||||||||||
Full Title: Phase 2 randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of Reltecimod as compared to placebo in addition to standard of care in patients with ... | ||||||||||||||||||||||||||||
Medical condition: Acute kidney injury due to intra-abdominal infection/sepsis | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: FR (Completed) BE (Prematurely Ended) NL (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
